ArticleSouth Asian journal of cancer2025

Feasibility, Safety, and Factors Predicting Completion of CROSS Protocol-Based Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma: Experience from an Indian Tertiary Care Cancer Center.

Suraj Surendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.